Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.
Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.
benzinga_article
Supernus Pharma shares trading higher after the company reported better-than-expected Q2 financial results. The company also announced a merger with Indivior Pharma to create diversified, CNS biopharmaceutical company.
